Rejection of intraocular tumors by CD4+ T cells without induction of phthisis

Journal of Immunology

Volumn 167, Issue 10, 2001, Pages 5832-5837

  Schurmans, L R H M ^a   Diehl, L ^a   Den Boer, A T ^a   Sutmuller, R P M ^a   Boonman, Z F H M ^a   Medema, J P ^a   Van der Voort, E I H ^a   Laman, J ^a   Melief, C J M ^a   Jager, M J ^a   Toes, R E M ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; FAS LIGAND; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; PERFORIN; TUMOR NECROSIS FACTOR ALPHA;

ADOLESCENT; ANIMAL CELL; ANIMAL MODEL; ARTICLE; CELL TRANSFORMATION; CELLULAR IMMUNITY; CONTROLLED STUDY; DELAYED HYPERSENSITIVITY; EMBRYO; HELPER CELL; IMMUNE DEFICIENCY; INTRAOCULAR TUMOR; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE; TUMOR GROWTH; TUMOR IMMUNITY; TUMOR REJECTION;

EID: 0035889888     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.167.10.5832     Document Type: Article

References (24)

1. Systemic immune unresponsiveness induced in adult mice by anterior chamber presentation of minor histocompatibility antigens
2. Does innate immune privilege exist?
3. Immune privilege, tumors, and the eye
4. The role of FasL-induced apoptosis in immune privilege
5. Immunoregulation of intraocular tumors
6. Immunologic evaluation of spontaneous regression of an intraocular murine melanoma
7. Destructive and nondestructive patterns of immune rejection of syngeneic intraocular tumors
8. Successful immunotherapy of an intraocular tumor in mice
9. Eradication of adenovirus E1-induced tumors by E1A-specific cytotoxic T lymphocytes
10. An adenovirus type 5 early region 1B-encoded CTL epitope-mediating tumor eradication by CTL clones is down-modulated by an activated ras oncogene
11. Deviant immune responses to allogeneic tumors injected intracamerally and subcutaneously in mice
12. Induction of anterior chamber-associated immune deviation requires an intact, functional spleen
13. Spontaneous immune rejection of intraocular tumors in mice
14. The cell biology of CTL killing
15. Lymphocyte-mediated cytotoxicity: Two pathways and multiple effector molecules
16. Lymphocyte-mediated cytotoxicity in vitro and in vivo: Mechanisms and significance
17. Rejection of intraocular tumors from transgenic mice by tumor-infiltrating lymphocytes
18. NKT cell-mediated repression of tumor immunosurveillance by IL-13 and the IL-4R-STAT6 pathway
19. Immune suppression and skin cancer development: Regulation by NKT cells
20. Immune privilege: Keeping an eye on natural killer T cells
21. CD1-reactive natural killer T cells are required for development of systemic tolerance through an immune-privileged site
22. Adoptive T cell therapy of tumors: Mechanisms operative in the recognition and elimination of tumor cells
23. (+) T cells in the antitumor immune response
24. + T cell-mediated tumor rejection involves inhibition of angiogenesis that is dependent on IFNγ receptor expression by nonhematopoietic cells